yttrium has been researched along with protoporphyrin ix in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, JY; Fang, YP; Hu, CH; Lee, WR; Shen, SC | 1 |
| Arellano, DL; Chauhan, K; Fournier, PGJ; Hirata, GA; Jain, A; Juárez, P; Sengar, P; Verdugo-Meza, A | 1 |
| Borbón-Nuñez, HA; Chauhan, K; Contreras, OE; Garcia-Tapia, K; Hirata, GA; Jain, A; Juarez-Moreno, K; Sengar, P; Tiznado, H | 1 |
| Gao, BA; Li, WT; Lin, HC; Madanayake, TW; Niu, Q; Ping, Z; Tao, C; Yan, SQ | 1 |
4 other study(ies) available for yttrium and protoporphyrin ix
| Article | Year |
|---|---|
In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Topics: Administration, Cutaneous; Aluminum; Aminolevulinic Acid; Animals; Carcinoma, Basal Cell; Cell Line, Tumor; Erbium; Female; In Vitro Techniques; Lasers; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin Absorption; Skin Neoplasms; Water Loss, Insensible; Yttrium | 2006 |
Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Folic Acid; Luminescent Agents; Male; Mice; Nanocomposites; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Protoporphyrins; Reactive Oxygen Species; Silicon Dioxide; Yttrium | 2018 |
Dual-photosensitizer coupled nanoscintillator capable of producing type I and type II ROS for next generation photodynamic therapy.
Topics: Aluminum; Animals; Cell Survival; Mice; Molecular Structure; Nanocomposites; Particle Size; Photochemotherapy; Photosensitizing Agents; Praseodymium; Protoporphyrins; Reactive Oxygen Species; Surface Properties; Tumor Cells, Cultured; Yttrium; Zinc Oxide | 2019 |
Aptamer-guided upconversion nanoplatform for targeted drug delivery and near-infrared light-triggered photodynamic therapy.
Topics: Antineoplastic Agents; Aptamers, Nucleotide; Biocompatible Materials; Cell Membrane Permeability; Cell Movement; Delayed-Action Preparations; Drug Liberation; Fluorescent Dyes; Fluorides; HeLa Cells; Humans; Infrared Rays; Nanocapsules; Oligodeoxyribonucleotides; Pharmaceutical Preparations; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Protoporphyrins; Reactive Oxygen Species; Yttrium | 2020 |